Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 10, 2025
Global Clean Technology Innovators Honored in 2025 CleanTech Breakthrough Awards Program
GlobeNewswire
·
April 10, 2025
LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- CleanTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout climate and clean technology companies, products and services around the globe, today …
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …
NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET
GlobeNewswire
·
April 10, 2025
HOLLYWOOD, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of tech-enabled engineering, certification, and consulting solutions, will announce its financial results for the first quarter ended …
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire
·
April 10, 2025
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need …
Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis
GlobeNewswire
·
April 10, 2025
– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a patient survey conducted in partnership with the National …
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire
·
April 10, 2025
Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes …
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
GlobeNewswire
·
April 10, 2025
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …
Byrna Technologies Fiscal First Quarter 2025 Results
GlobeNewswire
·
April 10, 2025
ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China
GlobeNewswire
·
April 10, 2025
FREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has been …
Cerence AI Honored with HARMAN's Best Technology Award
GlobeNewswire
·
April 10, 2025
BURLINGTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has been awarded the Best Technology Award by HARMAN during its …
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
GlobeNewswire
·
April 10, 2025
A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in Indonesia and Australia – catalysts for revenue in 2026 …
BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
GlobeNewswire
·
April 10, 2025
BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpoint Highly expressed on the cell surfaces of both tumor and immune cells, B7-H3 is a promising anti-cancer target for drugs both effecting cancer cells and blocking …
NevGold Discovers More Significant Oxide Gold-Antimony Results: 1.70 g/t AuEq Over 169.2 Meters (0.89 g/t Au And 0.18% Antimony), Including 2.85 g/t AuEq Over 54.4 Meters (2.26 g/t Au And 0.13% Antimony), and Also Including 13.15 g/t AuEq Over 3.1…
GlobeNewswire
·
April 10, 2025
Vancouver, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …
Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
GlobeNewswire
·
April 10, 2025
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April 10, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …
Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete
GlobeNewswire
·
April 10, 2025
Key Findings: 92% of organizations are concerned about ransomware attacks due to VPN vulnerabilities 93% of organizations fear backdoor vulnerabilities from third-party VPN connections 81% of organizations are adopting or planning to adopt zero trust …
American Rebel CEO Andy Ross Appears on Miami TV WSFL – Home of the Florida Panthers and is Featured in the New York Post for his Meetings at Mar-A-Lago as the Brand Continues to Expand its Footprint in Florida
GlobeNewswire
·
April 10, 2025
Miami Television Appearance and Investor Meetings at Mar-a-Lago Signal Big Moves for the Nation’s Fast-Growing Beer Brand – American Rebel Light Beer Nashville, TN, April 10, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American …
RedCloud Launches Red101 Agentic AI and new actionable market insights, advancing supply chain accessibility for global and local trade
GlobeNewswire
·
April 10, 2025
LONDON, April 10, 2025 (GLOBE NEWSWIRE) -- Trading platform company RedCloud Holdings plc ("RedCloud" or the "Company") has announced the launch of its innovative Red101 agentic AI technology providing intuitive trading intelligence to its platform in fast …
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
GlobeNewswire
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and …
ZenaTech Closes Miller Land Surveying Corporation, a Third Southeast Acquisition and a Fourth Nationally for the Drone as Service (DaaS) Rollout
GlobeNewswire
·
April 10, 2025
VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and …
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
GlobeNewswire
·
April 10, 2025
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected Brain Regions – MELBOURNE, Australia and SAN FRANCISCO, April 10, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX …